For example, overexpression of EFEMP1 eliminated tumor development and suppressed angiogenesis and VEGFA expression in hepatocellular carcinoma, gastric and prostate cancers, and glioblastoma [84,85], while the converse was true with ovarian and breast cancers [86]. This evidence concerns the gene EFEMP1 and glioblastoma.